谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Abstract OT3-22-01: First-in-human Global Multi-Center Study of RLY-2608, a Pan Mutant and Isoform Selective PI3Kα Inhibitor, As a Single Agent in Advanced Solid Tumor Patients and in Combination with Fulvestrant in Patients with Advanced Breast Cancer

Andreas Varkaris,Erika Hamilton,Jason Henry,Alexander I. Spira,Alison M. Schram,Julia E. McGuinness,Gege Tan,Xiaoyan Li,Tamieka Hunter,Ramin Samadani,Alison Timm,Djuro Karanovic,Vivek Subbiah,Cesar A. Perez

Cancer Research（2023）

引用 0|浏览34
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要